Cargando…
Safety Evaluation in Healthy Colombian Volunteers of P2Et Extract Obtained from Caesalpinia spinosa: Design 3+3 Phase I Clinical Trial
The polyphenol-enriched extract called P2Et derived from Caesalpinia spinosa (C. spinosa) had antitumor and immunomodulatory activities reported in breast cancer, leukemia, and melanoma. The aim of this study was to evaluate the safety and maximum tolerated dose of P2Et extract in Colombian healthy...
Autores principales: | Duran, María I, Ballesteros-Ramírez, Ricardo, Tellez, Angélica, Torregrosa, Lilian, Olejua, Peter A, Galvis, Silvia, Urueña, Claudia, Fiorentino, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890855/ https://www.ncbi.nlm.nih.gov/pubmed/35251213 http://dx.doi.org/10.1155/2022/7943001 |
Ejemplares similares
-
Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa
por: Ballesteros-Ramírez, R., et al.
Publicado: (2020) -
Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)
por: Ballesteros-Ramírez, Ricardo, et al.
Publicado: (2023) -
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
por: Lasso, Paola, et al.
Publicado: (2020) -
Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model
por: Urueña, Claudia, et al.
Publicado: (2013) -
A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line
por: Castañeda, Diana M, et al.
Publicado: (2012)